tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

LABP

AbbVie completes the acquisition of Landos Biopharma
The FlyAbbVie completes the acquisition of Landos Biopharma
1M ago
ABBV
LABP
AbbVie Completes Acquisition of Landos Biopharma
PremiumPress Releases
AbbVie Completes Acquisition of Landos Biopharma
1M ago
ABBV
LABP
Landos Biopharma’s Latest Deal Faces Tough Regulatory Gauntlet: HSR Act and FTC Scrutiny May Impose Delays and Costs
PremiumCompany Announcements
Landos Biopharma’s Latest Deal Faces Tough Regulatory Gauntlet: HSR Act and FTC Scrutiny May Impose Delays and Costs
2M ago
LABP
Landos Biopharma downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Landos Biopharma downgraded to Neutral from Buy at H.C. Wainwright
3M ago
LABP
This Biopharma Stock Outperformed MSTR and SMCI in March 2024
PremiumMarket News
This Biopharma Stock Outperformed MSTR and SMCI in March 2024
3M ago
ABBV
LABP
Landos Biopharma’s Definitive Merger with AbbVie Subsidiary
PremiumCompany AnnouncementsLandos Biopharma’s Definitive Merger with AbbVie Subsidiary
3M ago
8K
LABP
Landos Biopharma Inc trading resumes
PremiumThe Fly
Landos Biopharma Inc trading resumes
3M ago
LABP
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
PremiumPress Releases
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
3M ago
LABP
AbbVie to acquire Landos Biopharma for $20.42 per share in cash plus CVR
PremiumThe Fly
AbbVie to acquire Landos Biopharma for $20.42 per share in cash plus CVR
3M ago
ABBV
LABP
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
PremiumPress Releases
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
3M ago
ABBV
LABP
AbbVie to acquire Landos Biopharma got $20.42 per share in cash
PremiumThe Fly
AbbVie to acquire Landos Biopharma got $20.42 per share in cash
3M ago
ABBV
LABP
AbbVie to acquire Landos Biopharma for $20.42 per share in cash
PremiumThe Fly
AbbVie to acquire Landos Biopharma for $20.42 per share in cash
3M ago
ABBV
LABP
Landos Biopharma Inc trading halted, news pending
PremiumThe FlyLandos Biopharma Inc trading halted, news pending
3M ago
LABP
Landos Biopharma Provides Business Update and Reports Fourth Quarter and Full Year 2023 Results
PremiumPress Releases
Landos Biopharma Provides Business Update and Reports Fourth Quarter and Full Year 2023 Results
4M ago
LABP
Landos Biopharma reports Q4 EPS (99c) vs ($1.30) last year
PremiumThe Fly
Landos Biopharma reports Q4 EPS (99c) vs ($1.30) last year
4M ago
LABP
Landos Biopharma, Inc. (LABP) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Landos Biopharma, Inc. (LABP) Q4 Earnings Cheat Sheet
4M ago
LABP
Landos Biopharma to Present New Data on Immunometabolism at the 19th Annual Congress of the European Crohn’s and Colitis Organisation
PremiumPress Releases
Landos Biopharma to Present New Data on Immunometabolism at the 19th Annual Congress of the European Crohn’s and Colitis Organisation
6M ago
LABP
Landos Biopharma publishes results of NX-13 Phase 1b study in UC
PremiumThe Fly
Landos Biopharma publishes results of NX-13 Phase 1b study in UC
8M ago
LABP
Landos Biopharma Publishes Results of NX-13 Phase 1b Study in Ulcerative Colitis in Journal of Crohn’s and Colitis
PremiumPress Releases
Landos Biopharma Publishes Results of NX-13 Phase 1b Study in Ulcerative Colitis in Journal of Crohn’s and Colitis
8M ago
LABP
Landos Biopharma Provides Company Update and Reports Third Quarter 2023 Results
PremiumPress ReleasesLandos Biopharma Provides Company Update and Reports Third Quarter 2023 Results
8M ago
LABP
Landos Biopharma reports Q3 EPS (94c) vs ($1.96) last year
PremiumThe Fly
Landos Biopharma reports Q3 EPS (94c) vs ($1.96) last year
8M ago
LABP
Landos Biopharma to Present at the American College of Gastroenterology 2023 Annual Scientific Meeting
PremiumPress Releases
Landos Biopharma to Present at the American College of Gastroenterology 2023 Annual Scientific Meeting
9M ago
LABP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >